These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38625181)

  • 1. Competition and firm recovery post-COVID-19.
    Bruhn M; Demirguc-Kunt A; Singer D
    Small Bus Econ (Dordr); 2023 May; ():1-32. PubMed ID: 38625181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Productivity and firm exit during the COVID-19 crisis: cross-country evidence.
    Muzi S; Jolevski F; Ueda K; Viganola D
    Small Bus Econ (Dordr); 2023; 60(4):1719-1760. PubMed ID: 38625239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small firms and the COVID-19 insolvency gap.
    Dörr JO; Licht G; Murmann S
    Small Bus Econ (Dordr); 2022; 58(2):887-917. PubMed ID: 38624681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green management, access to credit, and firms' vulnerability to the COVID-19 crisis.
    Aristei D; Gallo M
    Small Bus Econ (Dordr); 2023 Apr; ():1-33. PubMed ID: 38625207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lasting crisis affects R&D decisions of smaller firms: the Greek experience.
    Giotopoulos I; Kritikos AS; Tsakanikas A
    J Technol Transf; 2022 Aug; ():1-15. PubMed ID: 35967599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation to Immune: Empirical Evidence From COVID-19 Focused Enterprise Surveys.
    Khan K; Liu S; Xiong B; Zhang L; Li C
    Front Psychol; 2022; 13():850842. PubMed ID: 35432097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of environmental regulation on foreign firms' exit: from the perspective of competition.
    Tai L; Yan L
    Environ Sci Pollut Res Int; 2022 Mar; 29(11):15539-15550. PubMed ID: 34625904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Productivity of firms using relief policies during the COVID-19 crisis.
    Morikawa M
    Econ Lett; 2021 Jun; 203():109869. PubMed ID: 36540306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of COVID-19 related government response stringency and support policies: Evidence from European firms.
    Janzen B; Radulescu D
    Econ Anal Policy; 2022 Dec; 76():129-145. PubMed ID: 35959486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal and financial constraints and firm growth: small and medium enterprises (SMEs) versus large enterprises.
    Bui AT; Pham TP; Pham LC; Ta TKV
    Heliyon; 2021 Dec; 7(12):e08576. PubMed ID: 34977406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Business dynamism, sectoral reallocation and productivity in a pandemic.
    Ascari G; Colciago A; Silvestrini R
    Eur Econ Rev; 2023 Jul; 156():104473. PubMed ID: 37265687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are environmentally friendly firms more vulnerable during the COVID-19 pandemic?
    Zhang D; Fang Y
    J Clean Prod; 2022 Jun; 355():131781. PubMed ID: 35466288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local environmental legislation and employment growth: evidence from Chinese manufacturing firms.
    Wen L; Li H; Bian X
    Environ Dev Sustain; 2023 May; ():1-39. PubMed ID: 37363004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking What I Say and What I Do: Evidence From Perceived Competition Networks.
    Chen F; Xu J; Wang W; Liao F; Guo Y
    Front Psychol; 2022; 13():887510. PubMed ID: 35645854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crisis Preparedness of Healthcare Manufacturing Firms during the COVID-19 Outbreak: Digitalization and Servitization.
    Zhang J; Qi L
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34065212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of capital structure management in maintaining the financial stability of hotel firms during the pandemic-A global investigation.
    Thi Mai Nguyen L; Le D; Vu KT; Tran TK
    Int J Hosp Manag; 2023 Feb; 109():103366. PubMed ID: 36447774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.